Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
342
NCT02121353
Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 30, 2013
Completion: Jan 31, 2016
NCT02474134
Comparison Study of PF530 and Betaferon in Healthy Subjects
Phase: Phase 1
Start: Mar 31, 2015
Completion: Oct 31, 2015
NCT02655549
A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects
Start: Dec 31, 2015
Completion: Jun 30, 2017
NCT02656810
A Comparison Study of PF708 and Forteo in Healthy Subjects
Completion: Jul 31, 2016
NCT03002428
A Comparison of PF708 and Forteo in Osteoporosis Patients
Phase: Phase 3
Start: Dec 31, 2016
Completion: May 31, 2018